The first acquisition of a non-profit target restructuring project passed after the implementation of the GEM reform.

On June 26, 2026, Maipu Medical issued shares and paid cash to purchase assets, which was approved by the restructuring committee of the Shenzhen Stock Exchange. This is the first acquisition reorganization project to pass after the implementation of the ChiNext reform on April 10. The non-profit target acquired by Maipu Medical this time is Yi Jie Medical, an innovative company in the domestic neurointerventional device sector, with products that are among the industry's best and breaking the industry pattern of long-term reliance on imported high-end neurointerventional devices. However, due to factors such as the rapid expansion of products in the market introduction period and continuous high research and development investment, the target company has not been profitable in the last three years. This transaction will help Maipu Medical complete a dual-track layout of "neurosurgery + neurointervention", achieving synergies between both sides' technologies, industrial chain resources, and market channels. The transaction also includes differentiated performance commitment arrangements, balancing the reality of the incubation period with future profit expectations.